ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 171 filers reported holding ANIKA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $55 | -86.2% | 2,962 | -80.7% | 0.00% | -100.0% |
Q2 2023 | $400 | -15.3% | 15,376 | -6.6% | 0.00% | 0.0% |
Q1 2023 | $472 | +8.8% | 16,461 | +12.1% | 0.00% | 0.0% |
Q4 2022 | $434 | -99.9% | 14,687 | +0.4% | 0.00% | 0.0% |
Q3 2022 | $348,000 | +6.7% | 14,627 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $326,000 | -1.2% | 14,627 | +14.4% | 0.00% | 0.0% |
Q1 2022 | $330,000 | -27.9% | 12,787 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $458,000 | -16.6% | 12,787 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $549,000 | -0.7% | 12,787 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $553,000 | +5.3% | 12,787 | -0.7% | 0.00% | 0.0% |
Q1 2021 | $525,000 | -16.5% | 12,875 | -7.5% | 0.00% | 0.0% |
Q4 2020 | $629,000 | +13.1% | 13,923 | -11.5% | 0.00% | 0.0% |
Q3 2020 | $556,000 | -13.8% | 15,724 | -8.4% | 0.00% | 0.0% |
Q2 2020 | $645,000 | +20.8% | 17,157 | -7.2% | 0.00% | 0.0% |
Q1 2020 | $534,000 | -38.6% | 18,482 | +9.3% | 0.00% | -50.0% |
Q4 2019 | $869,000 | +11.8% | 16,910 | -11.7% | 0.00% | 0.0% |
Q2 2019 | $777,000 | +30.8% | 19,150 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $594,000 | -26.4% | 19,150 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $807,000 | +31.6% | 19,150 | 0.0% | 0.00% | +100.0% |
Q2 2018 | $613,000 | -35.5% | 19,150 | 0.0% | 0.00% | -50.0% |
Q1 2018 | $951,000 | -7.8% | 19,150 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $1,032,000 | -11.6% | 19,150 | -4.6% | 0.00% | -33.3% |
Q3 2017 | $1,168,000 | +11.6% | 20,070 | -5.4% | 0.00% | 0.0% |
Q2 2017 | $1,047,000 | +13.7% | 21,220 | 0.0% | 0.00% | +50.0% |
Q1 2017 | $921,000 | -2.3% | 21,220 | +10.3% | 0.00% | -33.3% |
Q4 2016 | $943,000 | -50.9% | 19,246 | -52.1% | 0.00% | 0.0% |
Q3 2016 | $1,920,000 | +91.4% | 40,150 | +114.6% | 0.00% | 0.0% |
Q2 2016 | $1,003,000 | +1153.8% | 18,709 | +939.4% | 0.00% | – |
Q1 2016 | $80,000 | +15.9% | 1,800 | 0.0% | 0.00% | – |
Q4 2015 | $69,000 | +21.1% | 1,800 | 0.0% | 0.00% | – |
Q3 2015 | $57,000 | -3.4% | 1,800 | 0.0% | 0.00% | – |
Q2 2015 | $59,000 | -20.3% | 1,800 | 0.0% | 0.00% | – |
Q1 2015 | $74,000 | +1.4% | 1,800 | 0.0% | 0.00% | – |
Q4 2014 | $73,000 | +10.6% | 1,800 | 0.0% | 0.00% | – |
Q3 2014 | $66,000 | – | 1,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Caligan Partners LP | 591,675 | $17,513,580 | 14.58% |
Trigran Investments, Inc. | 1,564,541 | $46,310,413 | 4.64% |
DIKER MANAGEMENT LLC | 22,458 | $664,757 | 0.77% |
Virtus Fund Advisers, LLC | 3,490 | $103,304 | 0.74% |
Portolan Capital Management | 207,900 | $6,153,840 | 0.61% |
Virtus Investment Advisers, Inc. | 16,086 | $476,146 | 0.32% |
Ranger Investment Management | 140,205 | $4,150,068 | 0.31% |
BOOTHBAY FUND MANAGEMENT, LLC | 367,510 | $10,878,296 | 0.25% |
Riverwater Partners LLC | 9,778 | $289,429 | 0.25% |
Legato Capital Management LLC | 7,556 | $223,658 | 0.04% |